Efficacy and Safety of Statins in the Treatment of Essential Hypertension in China: A Systematic Review of Randomized Controlled Trials
张春燕,杨静,冯婉玉
DOI: https://doi.org/10.6039/j.issn.1001-0408.2013.20.25
2013-01-01
Abstract:OBJECTIVE:To evaluate the efficacy and safety of statins in the treatment of essential hypertension.METHODS:Retrieved from Cochrane library,Pubmed,EMbase,CBM,CNKI,VIP and Wanfang database,RCTs about the efficacy and safety of statins in the treatment of essential hypertension were collected completely in China.Methodological quality of included studies was evaluated,and effective data was extracted.Rev Man 5.1 software was used for data analysis.RESULTS:A total of 15 RCTs were included,involving 1 241 patients.Results of Meta-analysis showed that statins could reduce the levels of SBP [MD=-6.38,95%CI(-9.70,-3.06),P0.01],DBP[MD=-3.11,95%CI(-5.65,-0.57),P=0.02] and PP [MD=-4.65,95%CI(-6.12,-3.19),P0.01],at the same time they could reduce the level of TC [MD=-1.33,95%CI(0.12,-0.54),P0.01],TG [MD=-0.33,95%CI(-0.44,,-0.23),P0.01] and LDL-C[MD=-0.83,95%CI(-1.17,-0.48),P0.01],while increase the level of HDL-C [MD=0.12,95%CI(0.05,0.18),P0.01],there was significant difference between 2 groups.CONCLUSIONS:Statins are effective and safe in the treatment of essential hypertension.Because included studies are limited in quantity,results of the review want discretion and high-quality multiple-centered large-scale RCTs are required.